470 related articles for article (PubMed ID: 15647279)
21. p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor.
Uramoto H; Wetterskog D; Hackzell A; Matsumoto Y; Funa K
J Cell Sci; 2004 Oct; 117(Pt 22):5323-31. PubMed ID: 15454570
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression.
Kwon HS; Huang B; Ho Jeoung N; Wu P; Steussy CN; Harris RA
Biochim Biophys Acta; 2006; 1759(3-4):141-51. PubMed ID: 16757381
[TBL] [Abstract][Full Text] [Related]
23. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor.
Xiao H; Hasegawa T; Isobe K
J Biol Chem; 2000 Jan; 275(2):1371-6. PubMed ID: 10625687
[TBL] [Abstract][Full Text] [Related]
24. Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene.
Chang YC; Illenye S; Heintz NH
Mol Cell Biol; 2001 Feb; 21(4):1121-31. PubMed ID: 11158299
[TBL] [Abstract][Full Text] [Related]
25. Autoregulation of mouse histone deacetylase 1 expression.
Schuettengruber B; Simboeck E; Khier H; Seiser C
Mol Cell Biol; 2003 Oct; 23(19):6993-7004. PubMed ID: 12972616
[TBL] [Abstract][Full Text] [Related]
26. p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.
Momii Y; Izumi H; Shiota M; Onitsuka T; Abe T; Kobayashi H; Miyamoto N; Uchiumi T; Kohno K
Oncol Rep; 2007 Aug; 18(2):411-6. PubMed ID: 17611664
[TBL] [Abstract][Full Text] [Related]
27. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.
Wooten LG; Ogretmen B
J Biol Chem; 2005 Aug; 280(32):28867-76. PubMed ID: 15951564
[TBL] [Abstract][Full Text] [Related]
28. Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells.
Mishra DR; Chaudhary S; Krishna BM; Mishra SK
PLoS One; 2015; 10(4):e0124864. PubMed ID: 25923237
[TBL] [Abstract][Full Text] [Related]
29. Acetylated sp3 is a transcriptional activator.
Ammanamanchi S; Freeman JW; Brattain MG
J Biol Chem; 2003 Sep; 278(37):35775-80. PubMed ID: 12837748
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
31. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site.
Gao J; Chen T; Liu J; Liu W; Hu G; Guo X; Yin B; Gong Y; Zhao J; Qiang B; Yuan J; Peng X
Glia; 2009 Jul; 57(9):989-99. PubMed ID: 19062177
[TBL] [Abstract][Full Text] [Related]
32. Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells.
Bai L; Merchant JL
J Biol Chem; 2000 Sep; 275(39):30725-33. PubMed ID: 10899165
[TBL] [Abstract][Full Text] [Related]
33. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site.
Camarero N; Nadal A; Barrero MJ; Haro D; Marrero PF
Nucleic Acids Res; 2003 Mar; 31(6):1693-703. PubMed ID: 12626711
[TBL] [Abstract][Full Text] [Related]
34. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of c-Jun and Sp1 expression and p300 recruitment to gene promoter confers the trichostatin A-induced inhibition of 12(S)-lipoxygenase expression in EGF-treated A431 cells.
Chen CJ; Chang WC; Chen BK
Eur J Pharmacol; 2008 Sep; 591(1-3):36-42. PubMed ID: 18590721
[TBL] [Abstract][Full Text] [Related]
36. A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor.
Dong J; Tsai-Morris CH; Dufau ML
J Biol Chem; 2006 Jul; 281(27):18825-36. PubMed ID: 16651265
[TBL] [Abstract][Full Text] [Related]
37. Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo.
Li Q; Herrler M; Landsberger N; Kaludov N; Ogryzko VV; Nakatani Y; Wolffe AP
EMBO J; 1998 Nov; 17(21):6300-15. PubMed ID: 9799238
[TBL] [Abstract][Full Text] [Related]
38. Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters.
Caretti G; Salsi V; Vecchi C; Imbriano C; Mantovani R
J Biol Chem; 2003 Aug; 278(33):30435-40. PubMed ID: 12771133
[TBL] [Abstract][Full Text] [Related]
39. CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1.
Yang PM; Lin PJ; Chen CC
Epigenetics; 2012 Apr; 7(4):390-9. PubMed ID: 22419072
[TBL] [Abstract][Full Text] [Related]
40. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
